Skip to content
Open access

Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy

Jul 2026 · bioRxiv · 0 citations · 42 references
Medicine Biology
Read PDF